| 000 | 01097 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515220758.0 | ||
| 264 | 0 | _c20100712 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1744-7682 | ||
| 024 | 7 |
_a10.1517/14712598.2010.481666 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGordon, Erlinda M | |
| 245 | 0 | 0 |
_aRexin-G, a targeted genetic medicine for cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cMay 2010 |
||
| 300 |
_a819-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCyclin G1 _xgenetics |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 |
_aGenetic Therapy _xadverse effects |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHall, Frederick L | |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 10 _gno. 5 _gp. 819-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.2010.481666 _zAvailable from publisher's website |
| 999 |
_c19743565 _d19743565 |
||